9:00 AM

Evaluating Frequentist and Bayesian Confidence Intervals for Study Size Adjusted Risk Difference presented by Mr. Ben Duncan, Abbvie

10:00 AM

Enhancing the DMC Data Package Using Open Source Software, Artificial Intelligence, and LLMs presented by Dr. Melvin Munsaka, Abbvie

11:00 AM

A Structured Approach to Designing Pivotal Diagnostic Accuracy Studies for Noninvasive Tests Using Meta-Analytic Techniques presented by Dr. Ryan Butterfield and Dr. Ed De Vol, Siemens

1:00 PM

Multiple Testing in the Context of Group Sequential Designs presented by Dr. Yevgen Tymofyeyev and Dr. Michael Grayling, Johnson & Johnson

2:00 PM

 SMART-MC: Characterizing the Dynamics of Multiple Sclerosis Therapy Transitions Using a Covariate-Based Markov Model presented by Dr. Priyam Das, Virginia Commonwealth University

2:45 PM

Harnessing Simulation to Inform Endpoint Selection in Cardiovascular Trials presented Dr. Stephan Ogenstad, Statogen Consulting – Co-Authored by Greg Ginn, ReAltaSciences